Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 7, 2014; 20(21): 6515-6522
Published online Jun 7, 2014. doi: 10.3748/wjg.v20.i21.6515
Published online Jun 7, 2014. doi: 10.3748/wjg.v20.i21.6515
Table 1 Correlations between miR-132 expression and clinicopathological characteristics in colorectal cancer patients n (%)
Characteristics | n | miR-132 | P value | |
Low | High | |||
Age | 0.307 | |||
< 60 yr | 34 | 19 (55) | 15 (45) | |
≥ 60 yr | 28 | 12 (42) | 16 (58) | |
Gender | 0.437 | |||
Male | 37 | 20 (54) | 17 (46) | |
Female | 25 | 11 (44) | 14 (56) | |
CEA Level | 0.127 | |||
0-5 ng/mL | 32 | 13 (41) | 19 (59) | |
> 5 ng/mL | 30 | 18 (60) | 12 (40) | |
CA199 Level | 0.082 | |||
0-35 μ/mL | 46 | 20 (43) | 26 (57) | |
> 35 μ/mL | 16 | 11 (69) | 5 (31) | |
Tumor site | 0.796 | |||
Colon | 37 | 18 (49) | 19 (51) | |
Rectum | 25 | 13 (52) | 12 (48) | |
Tumor size (cm) | 0.016 | |||
≤ 5 | 41 | 16 (39) | 25 (61) | |
> 5 | 21 | 15 (71) | 6 (29) | |
Differentiation | 0.776 | |||
Well/moderate | 45 | 23 (51) | 22 (49) | |
Poor | 17 | 8 (47) | 9 (53) | |
Distant metastasis | 0.002 | |||
Yes | 32 | 10 (31) | 22 (69) | |
No | 30 | 21 (70) | 9 (30) | |
TNM stage | ||||
I/II | 11 | 2 (18) | 9 (72) | 0.020 |
III/IV | 51 | 29 (56) | 22 (44) |
-
Citation: Zheng YB, Luo HP, Shi Q, Hao ZN, Ding Y, Wang QS, Li SB, Xiao GC, Tong SL. miR-132 inhibits colorectal cancer invasion and metastasis
via directly targeting ZEB2. World J Gastroenterol 2014; 20(21): 6515-6522 - URL: https://www.wjgnet.com/1007-9327/full/v20/i21/6515.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i21.6515